Quick Answer
Nuo Therapeutics, Inc. reported Stockholders Equity of -$956.6 thousand for fiscal year 2025.
Nuo Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$956.6K | -286.2% |
| 2024 | $513.7K | -50.6% |
| 2023 | $1.04M | -52.6% |
| 2022 | $2.19M | +176.4% |
| 2021 | $792.8K | +251.7% |
| 2021 | -$522.5K | -1.3% |
| 2021 | -$515.8K | -1.3% |
| 2021 | -$509.2K | -1.1% |
| 2020 | -$503.5K | +51.3% |
| 2020 | -$1.03M | -1.5% |
| 2020 | -$1.02M | -2.3% |
| 2020 | -$996.2K | +17.6% |
| 2019 | -$1.21M | -1374.8% |
| 2018 | -$82.0K | -117.0% |
| 2017 | $482.9K | -96.1% |
| 2016 | $12.49M | -30.2% |
| 2016 | $17.89M | +148.9% |
| 2015 | -$36.56M | -336.4% |
| 2014 | $15.47M | -41.2% |
| 2013 | $26.31M | -30.8% |
| 2012 | $38.00M | +1058.1% |
| 2011 | $3.28M | +4240.7% |
| 2010 | -$79.3K | -108.1% |
| 2009 | $976.1K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$419.6K | -147.1% | +49.1% |
| June 30, 2025 | -$824.6K | -237.8% | -287.0% |
| March 31, 2025 | -$213.1K | -163.9% | -141.5% |
| December 31, 2024 | $513.7K | -50.6% | -42.3% |
| September 30, 2024 | $890.4K | +22.5% | +48.8% |
| June 30, 2024 | $598.5K | +27.1% | +79.5% |
| March 31, 2024 | $333.4K | -75.1% | -67.9% |
| December 31, 2023 | $1.04M | -52.6% | +43.0% |
- Nuo Therapeutics, Inc. showed a decrease of -286.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Nuo Therapeutics, Inc.’s stockholders equity has declined by 198.0% (from $976.1 thousand to -$956.6 thousand).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: